The relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA Project

Autor: Hobbs, MST, Jamrozik, K., Thompson, PL, Armstrong, BK, de Backer, G, De Craene, I, Van Onsem, P, Van Parys, L., De Henauw, S, De Bacquer, D, Kornitzer, M, Berghmans, L., Bara, L, de Smet, P, Jeanjean, M, Brohet, C, Kulbertus, HE, Degre, S, Lavenne, F, Jansens, D, Lefebvre, F., Beck, D, Wunsch, G., Bertrand, F., van Houte, M., Rime, B., Rorive, G, Hannot, R., Adrienne, A, Luyckx, A, Wolf, HK, Gregor, RD, Bata, IR, Brownell, B., Webber, K, Skodova´, Z, Pisa, Z., Berka, L., Cicha, Z., Cerovska´, J, Emrova´, R, Hoke, M, Hronkova, M., Pikhartova´, J., Grafnetter, D., Poledne, R., Vojtisek, P., Vorlicek, J., Wiesner, E, Schroll, M, Kirchhoff, M, Sjøl, A., Quitsau Lund, S, Tuomilehto, J, Puska, P., Vartiainen, E., Korhonen, H., Jousilahti, M, Ducimetie`re, P, Richard, JL, Bingham, A., Lang, T, Amouyel, P, Cottel, D., Nuttens, MC, Marecaux, N., Dallongeville, J., Salomez, J. L., Montaye, M., Steclebout, C, Arveiler, D, Schaffer, P, Haas, V, Wagner, A, Lamamy, N., Savouret, M, Houset, M., Pierau, F., Goetz, V, Ferrie`res, J, Ruidavets, JB, Cambou, JP, Rodier, P., Saulet, C, Greiser, E., Herman, B., Stu¨demann, G, Nu¨ssel, E., Osto¨r Lamm, E., Scheidt, R., Morgenstern, W., Stadler, M, Ganova, M, Keil, U, Tietze, M., Banos, R., Do¨ring, A., Filipiak, B, Barth, W, Heinemann, L, Muche, J., Schmalfuss, S., Assmann, A., Bo¨thig, S., Voigt, G., Brasche, S., Quietzsch, D., Classen, E, Sigfu´sson, N, Gudmundsdo´ttir, II, Stefa´nsdo´ttir, I, Thorsteinsson, T., Sigvaldason H, Menotti, A, Giampaoli, S., Verdecchia, A, Righetti, G., De Pasquale, B., Di Raimo, P, Forte, E., Majetta, A, Vanuzzo, D, Feruglio, GA, Pilotto, L., Cignacco, G., Marini, R., Zilio, G, Cesana, GC, Ferrario, M, Sega, R., Mocarelli, P, BRAMBILLA, PAOLO, Bluzhas, J, Domarkiene, S., Tamosiunas, A., Reklaitiene, R, Beaglehole, R, Jackson, R, Bonita, R, Stewart, A., Mahon, V, Bingley, W, Pajak, A, Sznajd, J, Kawalec, E., Pazucha, T., Malczewska, M., Mo´rawska, I, Rywik, SL, Broda,V, Polakowska, M., Kurjata, P, Varlamova, A, Britov, A., Konstantinov, V, Timofeeva, V, Alexandri, V, Konstantinova, O, Nikitin, Y.u. P, Malyutina, S., Gafarov, V, Feigin, V, Sans, S., Balaguer Vintro´, V, Balana`, V, Gonzalez, V, Gomez, V, Borras, V, Rode´s, A, Wilhelmsen, L, Harmsen, P., Rosengren, A., Lappas, G, Asplund, K., Huhtasaari, F., Stegmayr, B., Lundberg V, Gutzwiller, F, Paccaud, F., Rickenbach, M., Wietlisbach, V., Barazzoni, F, Mainieri, F., Tullen, B, Evans, V, McCrum, EE, Falconer, T, Cashman, S., Patterson, C., Kerr, M., O’Reilly, D., Scott, A., McConville, M., McMillan, I., McMaster, D, Tunstall Pedoe, H., Smith, WCS, Tavendale, R., Crombie, V, Barrett, K., Brown, C., Shewry, M., Hannh, M. K, Morrisson, C, Planojevic, M, Jakovljevic, D., Svircevic, A., Mirilov, V., Strasser, V., Mendis, S., Martin8, I, Gyarfas8, V, Pı´_sa8, V, Dodu8, S. R. A., Bo¨thig8, S., Watson, M. J., Hill, M., Price, A, Kuulasmaa, K., Tuomilehto, J., Ruokokoski, E, Rajakangas, A. M., Ma¨kinen, M., Virman Ojanen, T, Palonen, L., Akkila, J, Cepaitis, Z., Molarius, A., Moltchanov, V., Tolonen, H, Grafnetter, D, Dobson, A., Fortmann, SP, Shatchkute, A, Zaitsev, V, Epstein, FH, Feinleib, M, Karvonen, MJ, Prineas, RJ, Williams, OD

Publikováno v: Europe PubMed Central

Background and aims: The association between adiposity measures and dyslipidemia has seldom been assessed in a multipopulational setting. Methods and results: 27 populations from Europe, Australia, New Zealand and Canada (WHO MONICA project) using he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4a774a0f824f4d0c34bac75cb0d2c0
https://doi.org/10.1016/j.numecd.2011.09.002

The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson's Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On.

Autor: Männistö, Pekka T.¹ (AUTHOR), Keränen, Tapani² (AUTHOR), Reinikainen, Kari J.² (AUTHOR), Hanttu, Anna³ (AUTHOR), Pollesello, Piero⁴ (AUTHOR) piero.pollesello@orionpharma.com

Publikováno v: Neurology & Therapy. Aug2024, Vol. 13 Issue 4, p1039-1054. 16p.

Haemodynamic dose-efficacy of levosimendan in healthy volunteers

Autor: Akkila J, Jyrki Lilleberg, Häyhä M, Stig Sundberg, Markku S. Nieminen

Publikováno v: European journal of clinical pharmacology. 47(3)

Levosimendan is a new calcium-sensitiser intended for the treatment of congestive heart failure. The results of preclinical studies indicate it has positive inotropic and vasodilator effects. In the open study reported here up to 5 mg levosimendan an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2508b8abe25eb3f6ed02ede106797c1
https://pubmed.ncbi.nlm.nih.gov/7867680

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Short-term effects of sacubitril/valsartan therapy on myocardial oxygen consumption and energetic efficiency of cardiac work in heart failure with reduced ejection fraction: A randomized controlled study.

Autor: Nesterov SV; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland., Räty J; Department of Clinical Physiology, Nuclear Medicine and PET, Turku University Hospital, Turku, Finland., Nammas W; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Heart Center, Turku University Hospital and University of Turku, Turku, Finland., Maaniitty T; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Department of Clinical Physiology, Nuclear Medicine and PET, Turku University Hospital, Turku, Finland., Galloo X; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Stassen J; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Laurila S; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Heart Center, Turku University Hospital and University of Turku, Turku, Finland., Vasankari T; Heart Center, Turku University Hospital and University of Turku, Turku, Finland., Huusko J; Novartis Finland, Espoo, Finland., Bax JJ; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Saraste A; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Heart Center, Turku University Hospital and University of Turku, Turku, Finland., Knuuti J; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.; Department of Clinical Physiology, Nuclear Medicine and PET, Turku University Hospital, Turku, Finland.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2024 Jan; Vol. 26 (1), pp. 117-126. Date of Electronic Publication: 2023 Nov 16.